A Therapeutic Perspective for Proliferative Vitreoretinopathy Based on the Inhibition of Epithelial-mesenchymal Transition by MiR-194

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 May 16

PMID 32411748

Citations 1

Authors

Maria Bencivenga

Ilaria Decimo

Giorgio Malpeli

Affiliations

Soon will be listed here.

Citing Articles

Unveiling the mechanisms and challenges of cancer drug resistance.

Khan S, Fatima K, Aisha S, Malik F Cell Commun Signal. 2024; 22(1):109.

PMID: 38347575 PMC: 10860306. DOI: 10.1186/s12964-023-01302-1.

References

Xu S, Witmer P, Lumayag S, Kovacs B, Valle D . MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem. 2007; 282(34):25053-66. DOI: 10.1074/jbc.M700501200. View

Chen Z, Mei Y, Lei H, Tian R, Ni N, Han F . LYTAK1, a TAK1 inhibitor, suppresses proliferation and epithelial‑mesenchymal transition in retinal pigment epithelium cells. Mol Med Rep. 2016; 14(1):145-50. PMC: 4918529. DOI: 10.3892/mmr.2016.5275. View

Zhang J, Yuan G, Dong M, Zhang T, Hua G, Zhou Q . Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition. Histochem Cell Biol. 2016; 147(3):367-375. DOI: 10.1007/s00418-016-1484-x. View

Ricciardi M, Malpeli G, Bifari F, Bassi G, Pacelli L, Nwabo Kamdje A . Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. PLoS One. 2012; 7(5):e35639. PMC: 3342330. DOI: 10.1371/journal.pone.0035639. View

Chou C, Shrestha S, Yang C, Chang N, Lin Y, Liao K . miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2017; 46(D1):D296-D302. PMC: 5753222. DOI: 10.1093/nar/gkx1067. View

Liu Y, Xin Y, Ye F, Wang W, Lu Q, Kaplan H . Taz-tead1 links cell-cell contact to zeb1 expression, proliferation, and dedifferentiation in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2010; 51(7):3372-8. PMC: 2904003. DOI: 10.1167/iovs.09-4321. View

Yang S, Li H, Li M, Wang F . Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Discov Med. 2015; 20(110):207-17. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Postigo A, Depp J, Taylor J, Kroll K . Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 2003; 22(10):2453-62. PMC: 155984. DOI: 10.1093/emboj/cdg226. View

10.

Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S . MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways. Oncotarget. 2018; 9(51):29753-29771. PMC: 6049865. DOI: 10.18632/oncotarget.25707. View

11.

Nagasaka Y, Kaneko H, Ye F, Kachi S, Asami T, Kato S . Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2017; 58(1):221-229. DOI: 10.1167/iovs.16-20513. View

12.

Gregory P, Bracken C, Smith E, Bert A, Wright J, Roslan S . An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011; 22(10):1686-98. PMC: 3093321. DOI: 10.1091/mbc.E11-02-0103. View

13.

Palomares-Ordonez J, Sanchez-Ramos J, Ramirez-Estudillo J, Robles-Contreras A . Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Arch Soc Esp Oftalmol (Engl Ed). 2018; 94(1):12-17. DOI: 10.1016/j.oftal.2018.08.002. View

14.

Hao Y, Baker D, Ten Dijke P . TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int J Mol Sci. 2019; 20(11). PMC: 6600375. DOI: 10.3390/ijms20112767. View

15.

Du J, Zhang X, Cao H, Jiang D, Wang X, Zhou W . MiR-194 is involved in morphogenesis of spiral ganglion neurons in inner ear by rearranging actin cytoskeleton via targeting RhoB. Int J Dev Neurosci. 2017; 63:16-26. DOI: 10.1016/j.ijdevneu.2017.09.004. View

16.

Wellner U, Schubert J, Burk U, Schmalhofer O, Zhu F, Sonntag A . The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009; 11(12):1487-95. DOI: 10.1038/ncb1998. View

17.

Cui L, Lyu Y, Jin X, Wang Y, Li X, Wang J . miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1. Ann Transl Med. 2020; 7(23):751. PMC: 6990010. DOI: 10.21037/atm.2019.11.90. View

18.

Kwon O, Song J, Roh M . Retinal Detachment and Proliferative Vitreoretinopathy. Dev Ophthalmol. 2015; 55:154-62. DOI: 10.1159/000438972. View

19.

Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O, Chilosi M . Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. Br J Cancer. 2015; 112(6):1067-75. PMC: 4366889. DOI: 10.1038/bjc.2015.29. View

20.

Miao Q, Xu Y, Yin H, Zhang H, Ye J . KRT8 phosphorylation regulates the epithelial-mesenchymal transition in retinal pigment epithelial cells through autophagy modulation. J Cell Mol Med. 2020; 24(5):3217-3228. PMC: 7077598. DOI: 10.1111/jcmm.14998. View